A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS

A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS


A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS

Acronym: null
Other IDs: 20080p-000843
NCT Number: NCT00722800
Sponsor Collaborators: Massachusetts General Hospital|Bayer
Funding: Other|Industry


HIDRADENITIS SUPPURATIVA CLINICAL TRIAL STATUS

Recruiting Status: Terminated
Recruiting Genders: Female
Recruiting Age Groups: Child|Adult
Interventions: Drug: drospirenone and ethinyl estradiol (YAZ)|Drug: Placebo
Phases: Phase 2


CLINICAL STUDY DETAILS & RESULTS

STUDY TYPES: Interventional
STUDY DESIGNS: Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
Results First Received: May 6, 2013
Study Result (if available): Has Results
Primary Completion Date: December 2011
Outcome Measures: Mean Improvement in the Sartorius Severity Score at Month 6.|Change From Baseline in VAS Pain Scale at Month 6.|Change From Baseline in Dermatology Life Quality Index (DLQI) Score at Month 6.


CLINICAL STUDIES DATES & MILESTONES

First Received: July 24, 2008
Start Date: October 2008
Completion Date: December 2011
Last Updated: January 16, 2014
last Verified: January 2014


Source: https://ClinicalTrials.gov/show/NCT00722800


Public Domain Source: ClinicalTrials.gov query for “Hidradenitis suppurativa” clinical studies (last updated January 2016).


Tags:

HSAWARENESS.ORG | Fighting for Hidradenitis suppurativa (HS), a.k.a Acne Inversa Patient and Doctor Awareness ©2017 hidradenitissuppurativaawareness.org  All Rights Reserved. Your use of this website constitutes explicit agreement to our Terms of Use and Privacy Policies. This website does not provide medical advice, diagnosis or treatment.

Translate »

Log in with your credentials

Forgot your details?